Back to News
Market Impact: 0.3
Amneal Pharmaceuticals, Inc. Reports Third Quarter 2026 Net Revenue of $863 million
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Amneal Pharmaceuticals reported third-quarter 2026 net revenue of $863 million, up 10% from $785 million in the third quarter of 2025. The article fragment begins to report a net loss attributable to the company but provides no amount or further results, limiting assessment of overall performance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment
AMRX0.20
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- AMD’s OpenAI, Meta chip deals trigger $1 billion quarterly charge